Concurrent Investment Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Buy
71,999
+3,536
+5% +$1.05M 0.23% 92
2025
Q4
$18.7M Buy
68,463
+56,256
+461% +$15.3M 0.21% 101
2025
Q3
$3.3M Sell
12,207
-419
-3% -$114K 0.06% 331
2025
Q2
$3.48M Buy
12,626
+7,198
+133% +$1.96M 0.07% 292
2025
Q1
$1.44M Sell
5,428
-1,997
-27% -$493K 0.03% 444
2024
Q4
$1.72M Sell
7,425
-15
-0.2% -$3.45K 0.05% 359
2024
Q3
$1.64M Buy
7,440
+1,902
+34% +$394K 0.05% 360
2024
Q2
$1.09M Buy
5,538
+3,171
+134% +$655K 0.04% 407
2024
Q1
$510K Sell
2,367
-824
-26% -$173K 0.02% 543
2023
Q4
$672K Buy
+3,191
New +$681K 0.03% 418

Other funds holding CME

Concurrent Investment Advisors's CME Position: Q1 2026 in Review

Concurrent Investment Advisors increased its CME Group (CME) stake by 5.2% in Q1 2026, buying an estimated $1.05M and bringing the position to 71,999 shares worth $21.3M. The position accounts for 0.23% of the portfolio, ranked #92.

Concurrent Investment Advisors first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Concurrent Investment Advisors held 71,999 shares of CME Group worth $21.3M as of Q1 2026.
  • Concurrent Investment Advisors bought 3,536 CME Group shares in Q1 2026, an estimated $1.05M.
  • CME Group made up 0.23% of Concurrent Investment Advisors's portfolio in Q1 2026, its #92 holding.
  • Concurrent Investment Advisors first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.